HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million
Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million
You Might Also Like
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same.
